ABSTRACT Sixty seven patients with biopsy proven pulmonary sarcoidosis were prospectively studied to determine whether single point bronchoalveolar lavage cell counts were a useful indicator of functional outcome and whether repeated lavage helped in management. The mean follow up period was 25 (range 13-37) months. No patient was having corticosteroid treatment at the time of initial bronchoalveolar lavage. "High intensity alveolitis" (lymphocyte count > 28%) was present at the initial lavage in 42 patients. These patients showed a significant improvement in their pulmonary function and chest radiographs over the follow up period whereas patients with "low intensity alveolitis" did not. Of the 42 patients with high intensity alveolitis, 31 had chronic sarcoidosis (duration over two years, mean 80 months). These patients showed a significant improvement in FVC but not in TLCO. Corticosteroids resulted in greater functional and radiological improvement in the patients with high intensity alveolitis than in those with low intensity alveolitis. Repeat bronchoalveolar lavage in 34 patients, mean 8-4 months after the original lavage, showed a weak inverse relation between a reduced lymphocyte count and change in forced vital capacity and isotope uptake on a gallium scan. These correlations were too weak to make repeated cell counts useful in management. Our results suggest that high intensity alveolitis may be a favourable prognostic factor for lung function in pulmonary sarcoidosis, even in patients with chronic disease, but that repeat lavage adds little to the management of the individual patient.
Introduction
A major problem in pulmonary sarcoidosis is the prediction of which patients will develop pulmonary fibrosis. The assessment of disease activity is difficult. Many tests of activity have been devised, the most commonly used adjuncts to plain chest radiography and pulmonary function testing being determination of serum angiotensin converting enzyme activity,'-3 gallium-67 lung scanning,4 5 and bronchoalveolar lavage fluid differential cell counts with or without identification of lymphocyte subsets.67
The value of lavage fluid cell counts in predicting outcome and in evaluating the need for treatment is not clear. An episode of "high intensity alveolitis" (lymphocyte count > 28%) in untreated patients may Address for correspondence: Dr Noeleen Foley, Medical Unit, Middlesex Hospital, London WIN 8AA. Accepted 16 May 1989 be followed by deterioration in lung function in up to 87% of cases.8 A fall in the percentage of lymphocytes was correlated with clinical improvement, as gauged by change in the results of pulmonary function tests, chest radiographs, and values ofserum immunological markers.9 No correlation between the results of these investigations was found in another study.'0 That a high initial lymphocyte count is a poor prognostic indicator is now less widely accepted," 2 and Ward et al" proposed that the disparity between studies was due partly to genetic and racial differences, which influence the mode of presentation of sarcoidosis,"4 and also to differences in study populations.
The value of the bronchoalveolar lavage findings as a means of assessing the need for treatment and response to treatment has also been reviewed both favourably'5 and unfavourably.'6'8 Recently lavage fluid neutrophil counts have been reported to be of greater value than the lymphocyte count in predicting deterioration in lung function. '9 We investigated whether a single point broncho-732 Bronchoalveolar lavage cell counts as a predictor ofshort term outcome in pulmonary sarcoidosis alveolar lavage was of value in predicting which patients with pulmonary sarcoidosis would improve or deteriorate, and whether repeated lavage had a role in the management of patients with sarcoidosis.
Methods

PATIENTS
Sixty seven patients (33 male) underwent fibreoptic bronchoscopy and bronchoalveolar lavage for the diagnosis or assessment of the activity of their sarcoidosis. All patients had histologically proved sarcoidosis. Thirty three were white, 24 black, and 10 Asian. Their mean age was 42 years and mean duration of disease at the start of the study was 60 months, with a range from newly presented (13 patients) to 20 years. No patient was having corticosteroid treatment either at the time of initial lavage or during the preceding six months.
A chest radiograph was obtained for all patients before the initial lavage. In addition to the standard 0-IV staging system,20 chest radiographs were given a quantitative score according to the ILO/UC system, which is based on the numbers of rounded and irregular nodules in the three zones of each lung. 2 Giemsa. For this study "high intensity alveolitis" was defined as a lymphocyte count of28% or more oftotal cells, and "low intensity alveolitis" as a lymphocyte count of less than 28%.7 FOLLOW UP Patients were seen regularly and assessed by chest radiography and pulmonary function tests. Decisions to treat with corticosteroids were made on clinical grounds, without reference to lavage fluid cell counts. All 67 patients had repeat chest radiography and pulmonary function tests at the end ofthe study period (mean 25, range 13-37 months after initial lavage). All investigations, including lavage and gallium scanning, were repeated in 34 patients during the follow up period (mean 8-6, range 4-20 months).
Over the two years of follow up 24 of the 67 patients required oral corticosteroid treatment. Treatment was given for pulmonary disease if at least two of the following criteria were met: increase in pulmonary symptoms, deterioration in FVC or TLCO by 10% or more, or increased density of pulmonary shadowing on chest radiograph corresponding to an increase of more than two points on the ILO scoring system. Only four patients were treated exclusively for pulmonary sarcoidosis. Four were treated for hypercalcaemia, three for ophthalmic sarcoidosis, and one for cerebral sarcoidosis; the remaining 12 patients had one or more of the following: lupus pernio, bone cysts, lymph node enlargement, hepatic granulomas, splenomegaly, pyrexia, and sarcoidosis ofthe upper respiratory tract.
STATISTICAL METHODS
Simple regression analysis was used for continuous variables (for example, lymphocyte and neutrophil percentages and forced vital capacity (FVC) or carbon monoxide transfer factor (TLCO)) and for correlation of changes in these variables. Paired Students' t tests were used to assess the significance of the change from the first to the last measurement in the same patient. Non-parametric testing (Wilcoxon signed rank test) was used for differences between groups of data that did not have a normal distribution.
Result INITIAL CLINICAL ASSESSMENT
The chest radiograph was abnormal in 53 patients at the start ofthe study. Ofthese, 11 were stage I, 23 stage II, 12 stage III, and seven stage IV (a more detailed breakdown ofchest radiographs for patients with high intensity alveo}itis and low intensity alveolitis is given in table 1). The mean ILO score for the group at this time was 4 9 (SD 1-2, range 0-18). The mean FVC was 87% predicted (SD 18%, range 51-125%). The mean TLCO was 66% predicted (SD 20%, range 24-114%). Foley, Coral, Tung, Hudspith, James, Johnson diagnosed patients required corticosteroid treatment (one each for pulmonary sarcoidosis, ophthalmic sarcoidosis, and hepatosplenomegaly). Of the 34 patients who had a repeat lavage during the study, only four required treatment between lavages-one for pulmonary disease and three for extrapulmonary disease.
PREDICTIVE VALUE OF INITIAL LAVAGE
There was no significant relation between the initial lavage lymphocyte count and final outcome, whether judged by FVC, TLCO, or radiological score. Patients with initial high intensity alveolitis, however, showed a significant improvement in pulmonary function and chest radiograph over the two year follow up period (improvement in FVC: p < 0'001; TLCO: P < 0O005; ILO score: p < 005). Those with low intensity alveolitis showed no significant improvement in FVC or ILO score but their TLCO did improve significantly (fig 1) . There was no correlation between initial neutrophil count and change in pulmonary function or chest radiograph, neither was there any significant correlation between initial gallium uptake and change in these measurements. CHRONIC 
SARCOIDOSIS
As patients with "acute sarcoidosis" (particularly with bilateral hilar lymphadenopathy and erythema nodosum) have an excellent prognosis, we analysed the results from the 54 patients who had chronic disease separately. Of our 42 patients with high intensity alveolitis, 31 had chronic disease (mean duration 81 (SD 51) months. This group showed significant improvement in FVC over the period of the study (p < 0-001), but there was no significant change in TLCO or ILO score (fig 2) . The 14 patients with chronic disease and high intensity alveolitis who were treated with corticosteroids showed significant improvement in pulmonary function (change in mean FVC from 77% to 88% predicted (p < 0 005) and in mean TLCO from 55% to 61% predicted) and their ILO score fell, though not significantly (fig 3) . The untreated patients with chronic disease and high intensity alveolitis showed a small but significant improvement in FVC, and non-significant improvements in other pulmonary function measurements and in their chest radiograph.
Patients with chronic sarcoidosis and low intensity alveolitis at the onset of the study period (23 patients) showed no improvement in FVC or ILO score but significant improvement in TLCO (p < 0-01, fig 2) .
Only seven patients were treated with corticosteroids; they showed no significant change in FVC or TLCO, but had a fall in ILO score. The 16 untreated patients showed no change in FVC or ILO score, but had a significant rise in TLCO. (from a mean of 88% to 92% predicted), accompanied by a significant rise in TLCO (mean 68% to 74%; p < 0.05), with no significant change in the chest radiograph. Three patients had normal chest radiographs at the beginning of the study, which became abnormal during the course of follow up.
VALUE OF REPEAT LAVAGE
Lavage was repeated in 34 patients, on average 8-4 months after the initial lavage (range 4-20 months). A significant correlation was found between the fall in lavage fluid lymphocyte percentage and improvement in FVC (p < 0-05; fig 4) . No correlation was found between change in lymphocyte count and change in TLCO or ILO score. Twenty five patients also had a repeat gallium scan, and a weak correlation was found between fall in the percentage of lymphocytes and fall in gallium score (p < 0 05). Change in ILO profusion score was sigificantly correlated with change in TLCO 
